Taxol treatment of experimental proliferative vitreoretinopathy |
| |
Authors: | Stewart A Daniels Kevin G Coonley Marc O Yoshizumi |
| |
Institution: | (1) Vitreoretinal Division, Jules Stein Eye Institute, University of California, Los Angeles, 200 Stein Plaza, 90024-7007 Los Angeles, CA, USA |
| |
Abstract: | Taxol is a potent stabilizer of microtubules, and inhibitor of in vitro replication, migration, and contraction of fibroblasts. It has been found to limit the development of experimental tractional retinal detachments in nonvitrectomized rabbit eyes. We used taxol in vitrectomized, phakic rabbit eyes with experimentally induced proliferative vitreoretinopathy and tractional retinal detachments. Taxol was dissolved in 30% DMSO because of poor aqueous solubility. A single 0.1 ml intravitreal dose of 2 × 10–4
M taxol in 30% DMSO was injected immediately after 250000 heterologous corneal fibroblasts had been injected; 0.1 ml of 30% DMSO was injected into control eyes. Taxol reduced the incidence of tractional retinal detachments seen 3–4 weeks later. When taxol injection was delayed for 3 days after the initial intravitreal injection of fibroblasts into nonvitrectomized eyes, the extent of retinal detachments was reduced, but the incidence of retinal detachment was unchanged from the untreated eyes at the end of 4 weeks. These data indicate that taxol may be most useful when given early in the course of proliferative vitreoretinopathy.Dr. Stewart Daniels was an Abe Meyer Fellow |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|